US Patent 11787867 Anti-GITR antibodies and uses thereof
Patent 11787867 was granted and assigned to Regeneron Pharmaceuticals on October, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 19 Oct, 2023
Golden AI
Edits made to:
Infobox (+33 properties)
Article (+331 characters)
US Patent 11787867 Anti-GITR antibodies and uses thereof
Article
Patent abstract
Provided herein are antibodies, and antigen-binding fragments thereof that specifically bind glucocorticoid-induced tumor necrosis factor receptor (GITR), compositions comprising the antibodies or antigen-binding fragments thereof, and methods of using the same, including, e.g., methods of treatment using the same.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Bei Wang
Dimitris Skokos
Drew Dudgeon
Matthew Sleeman
Robert Babb
Rosalynn Molden
William Olson
Yu Huang
Date of Patent
October 17, 2023
Patent Application Number
17193586
Date Filed
March 5, 2021
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11787867 Anti-GITR antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
